LAURA INGRAHAM (HOST): And a new study -- this is really big. This just broke tonight from the French research team that was led by the renowned epidemiologist Didier Raoult, just posted online. This study offers more hope that the combination of hydroxychloroquine and azithromycin is helping COVID-19 patients.
Now, this was a study of 80 patients, more than double the size professor Raoult’s earlier study had, but it's still not controlled. Nevertheless, 54 of the patients had CT scans for COVID pneumonia. Only three of them required an ICU, and the median age was 52, that's fairly young. About two-thirds or so had underlying medical conditions, and the results were stunning.
This is what it said, in part. "By administering hydroxychloroquine combined with azithromycin, we were able to observe an improvement in all cases, except in one patient who arrived with an advanced form, who was over the age of 86 and in whom the evolution was irreversible. For all other patients in this cohort of 80 people, the combination of hydroxychloroquine and azithromycin resulted in a clinical improvement that appeared significant when compared to the natural evolution in patients with a definite outcome, as described in the literature."
Now, there's a lot to this. We're going to run through this with The Ingraham Angle medicine cabinet, as I'd like to call them, our medical experts, in just a few moments.